Ashley R. Hinson

Ashley R. Hinson

Pediatric Hematology Oncology | Hematology | Oncology
1001 Blythe Blvd.
Suite 3000
Charlotte, NC 28203

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Evaluation of Bleeding Disorders in the Newborn.

Evaluation of Bleeding Disorders in the Newborn.

Journal: Pediatric clinics of North America
Published: July 06, 2025

Emapalumab treatment in rheumatologic disease-associated hemophagocytic lymphohistiocytosis: a plain language summary.

Emapalumab treatment in rheumatologic disease-associated hemophagocytic lymphohistiocytosis: a plain language summary.

Journal: Immunotherapy
Published: June 18, 2025

Emapalumab use in malignancy-associated hemophagocytic lymphohistiocytosis in the United States: the REAL-HLH study.

Emapalumab use in malignancy-associated hemophagocytic lymphohistiocytosis in the United States: the REAL-HLH study.

Journal: Blood advances
Published: July 23, 2024

Emapalumab use in malignancy-associated hemophagocytic lymphohistiocytosis in the United States: The REAL-HLH study.

Emapalumab use in malignancy-associated hemophagocytic lymphohistiocytosis in the United States: The REAL-HLH study.

Journal: Blood advances
Published: July 23, 2024

Emapalumab Treatment in Patients With Rheumatologic Disease-Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review Study.

Emapalumab Treatment in Patients With Rheumatologic Disease-Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review Study.

Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: April 03, 2024

Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab.

Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab.

Journal: Blood advances
Published: November 27, 2023

Severe Thromboses in Neonates.

Severe Thromboses in Neonates.

Journal: Current pediatric reviews
Published: September 13, 2022

Recombinant von Willebrand factor for perioperative bleeding management in pediatric patient with allergy to plasma-derived von Willebrand factor.

Recombinant von Willebrand factor for perioperative bleeding management in pediatric patient with allergy to plasma-derived von Willebrand factor.

Journal: Pediatric blood & cancer
Published: April 21, 2022

Real-world experience in treating pediatric relapsed/refractory or therapy-related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortium.

Real-world experience in treating pediatric relapsed/refractory or therapy-related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortium.

Journal: Pediatric blood & cancer
Published: April 15, 2022

Levocarnitine for pegaspargase-induced hepatotoxicity in older children and young adults with acute lymphoblastic leukemia.

Levocarnitine for pegaspargase-induced hepatotoxicity in older children and young adults with acute lymphoblastic leukemia.

Journal: Cancer medicine
Published: April 09, 2021

Hemophagocytic Lymphohistiocytosis in Langerhans Cell Histiocytosis: A Case Report and Review of the Literature.

Hemophagocytic Lymphohistiocytosis in Langerhans Cell Histiocytosis: A Case Report and Review of the Literature.

Journal: Journal of pediatric hematology/oncology
Published: November 15, 2019

The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis.

The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 03, 2017
Showing 1-12 of 18

Last Updated: 09/26/2026